The Patent Finder

Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the CNS

Yeda Research and Development Co. Ltd.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 19 of these applications claim priority to application PCT/IL2015/050265, filed Mar 12, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,394,365Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease
In force
 · High confidence
Yeda Research and Development Co. Ltd.In force
High confidence
US 9,512,225Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease
In force
 · High confidence
Yeda Research and Development Co. Ltd.In force
High confidence
US 9,512,227Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease
In force
 · High confidence
Yeda Research and Development Co., Ltd.In force
High confidence
US 9,534,052Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease
In force
 · High confidence
Yeda Research and Development Co., Ltd.In force
High confidence
US 9,856,318Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the CNS
In force
 · High confidence
Yeda Research and Development Co. Ltd.In force
High confidence
US 9,982,047Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease
In force
 · High confidence
Yeda Research and Development Co., Ltd.In force
High confidence
US 9,982,048Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease
In force
 · High confidence
Yeda Research and Development Co., Ltd.In force
High confidence
US 9,982,049Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease
In force
 · High confidence
Yeda Research and Development Co., Ltd.In force
High confidence
US 9,982,050Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease
In force
 · High confidence
Yeda Research and Development Co., Ltd.In force
High confidence
US 9,982,051Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the CNS
In force
 · High confidence
Yeda Research and Development Co., Ltd.In force
High confidence
12 more patents in this group · Pro
10 of 22 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 22.
Upgrade to Pro
20 of these are in force and held by Yeda Research and Development Co. Ltd..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited